Before You Sign: A Board-Level Diligence Framework for the Next Acquisition

Acquisition failures rarely announce themselves in the boardroom. They begin quietly, in the weeks before a letter of intent is signed, when enthusiasm for a strategic thesis crowds out the harder questions a disciplined holding company should be asking. Research consistently shows that a majority of acquisitions fail to create value for the acquirer—and the root causes are almost always visible in advance to anyone willing to look.

For diversified holding companies and multi-business enterprises, the stakes are compounded. A poorly fitted subsidiary does not merely underperform on its own; it consumes management attention, capital, and credibility that the rest of the portfolio could have used. What follows is a ten-question framework designed to be applied before the deal team falls in love with the target.

The Ten Questions

1. Who actually runs this business, and what happens to them?

Financial diligence can verify revenue; it cannot verify whether the CFO who built the forecasting model plans to stay. Boards should require a named leadership assessment—individual by individual—covering capability, retention risk, and succession depth. If the answer to 'what happens when the founder leaves?' is a shrug, the price has not been set correctly.

2. Does the target's management team know their own numbers?

Ask to see the internal reporting package the leadership team actually uses—not the sell-side deck. Gaps between the two reveal whether management operates on data or intuition. In a portfolio context, this question matters twice: once for the target's health, and once for the cost of integrating it into parent-level reporting.

3. What capital will this business need in the next three years?

Serial overpayers habitually underestimate follow-on investment. A target acquired at a reasonable multiple can still become a capital sink if deferred maintenance, technology debt, or working capital needs surface post-close. Model the capital request before the deal, not after the first quarterly review.

4. Would we buy this business if we could not change anything?

This question exposes the 'synergy mirage.' If the entire investment case depends on operational improvements the acquirer will impose, the board is not buying a company—it is underwriting a turnaround it has not yet priced.

5. Does the culture survive contact with ours?

Cultural fit is not a soft consideration in a diversified enterprise; it is an economic one. A high-autonomy subsidiary grafted onto a centralized parent will either resist integration or lose the very traits that made it valuable. Boards should ask specifically: which management practices at the target are load-bearing, and which parent policies would break them?

6. What is the customer concentration story?

A target deriving 40% of revenue from three accounts is a different investment than its pro forma suggests. Diligence should include direct conversations—or at minimum, contract reviews and churn analysis—that test whether key relationships are institutional or personal to the departing owner.

7. How would we exit this position?

It is uncomfortable to discuss divestiture before acquisition, but exit optionality is a discipline, not a pessimism. Are there natural buyers? Is the business separable from shared systems? A subsidiary with no plausible path to independence or sale can become a permanent drag on portfolio focus.

8. Where does this business sit on the cyclicality curve?

Targets are frequently shopped at peak earnings. Boards should require a through-cycle view of margins and demand, and ask what the business looked like in its last downturn. A company that has never weathered a recession has not yet been fully underwritten.

9. Who else wanted this deal, and why did they walk?

Competitive processes leave fingerprints. Where possible, corporate development teams should understand why prior suitors declined—or why a previous owner divested. The information asymmetry in a process usually favors the seller; this question claws some of it back.

10. What is our own capacity to absorb this?

The final question turns inward. Does the corporate team have the bandwidth to onboard another subsidiary? Is there a named integration owner with authority and time? Many portfolios fail not because the target was weak, but because the acquirer was already at capacity.

Using the Framework Well

The value of these questions lies less in the answers than in the process of demanding them. A board that requires written responses to all ten—before the investment committee vote—creates a record that disciplines both enthusiasm and hindsight. When a deal later struggles, the framework shows whether the risk was unforeseeable or simply unexamined.

Holding companies that outperform over time are not those that avoid acquisitions. They are those that treat every deal as a portfolio decision rather than a transaction: one more position in a long-term allocation, subject to the same scrutiny as the last one, and the next.